WAVE Life Sciences - Stock Price History | WVE
Historical daily share price chart and data for WAVE Life Sciences since 2021 adjusted for splits. The latest closing stock price for WAVE Life Sciences as of September 27, 2021 is 6.16.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
- The all-time high WAVE Life Sciences stock closing price was 55.20 on September 24, 2018.
- The WAVE Life Sciences 52-week high stock price is 12.17, which is 97.6% above the current share price.
- The WAVE Life Sciences 52-week low stock price is 4.82, which is 21.8% below the current share price.
- The average WAVE Life Sciences stock price for the last 52 weeks is 7.66.
|WAVE Life Sciences Historical Annual Stock Price Data
||Average Stock Price
||Annual % Change
||Medical - Biomedical and Genetics
WAVE Life Sciences Pte. Ltd. is a preclinical biopharmaceutical company. It designs, develops and commercializes nucleic acid therapeutic candidates for Huntington's disease, Duchenne muscular dystrophy and inflammatory bowel disease. Huntington's disease, the Company has programs targeting HTT SNP-1 and HTT SNP-2; DMD, targeting Exon 51 and in IBD, it is targeting SMAD7. The Company has late-stage discovery programs in epidermolysis bullosa simplex, in which it is targeting KRT14 SNP-1 and KRT14 SNP-2 and in DMD, it is focused on an additional DMD target, Activin Receptor type IIb. WAVE Life Sciences Pte. Ltd. is based in Singapore.